RIZZETTO, GIULIO
 Distribuzione geografica
Continente #
NA - Nord America 1.748
AS - Asia 777
EU - Europa 673
SA - Sud America 182
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.449
Nazione #
US - Stati Uniti d'America 1.718
SG - Singapore 306
CN - Cina 221
BR - Brasile 162
IT - Italia 149
RU - Federazione Russa 148
HK - Hong Kong 123
IE - Irlanda 81
SE - Svezia 66
GB - Regno Unito 51
DE - Germania 49
VN - Vietnam 49
CI - Costa d'Avorio 37
FR - Francia 34
FI - Finlandia 26
CA - Canada 20
IN - India 18
NL - Olanda 16
PL - Polonia 15
MA - Marocco 14
JP - Giappone 12
ZA - Sudafrica 12
AT - Austria 10
AR - Argentina 9
MX - Messico 9
BD - Bangladesh 8
BE - Belgio 8
ES - Italia 8
TR - Turchia 7
ID - Indonesia 5
IQ - Iraq 5
TH - Thailandia 5
CL - Cile 4
IL - Israele 4
LT - Lituania 4
EC - Ecuador 3
PH - Filippine 3
UZ - Uzbekistan 3
CZ - Repubblica Ceca 2
HU - Ungheria 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
UY - Uruguay 2
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
CO - Colombia 1
DZ - Algeria 1
EG - Egitto 1
GH - Ghana 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LB - Libano 1
PE - Perù 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.449
Città #
Ashburn 323
Dallas 210
Singapore 193
Chandler 171
Des Moines 141
Hong Kong 123
Boardman 97
New York 79
Dublin 73
Los Angeles 59
Beijing 46
The Dalles 39
Abidjan 37
Ancona 36
Moscow 35
Munich 33
Hefei 32
Chicago 24
Washington 20
Buffalo 18
Ho Chi Minh City 18
Seattle 18
Shanghai 18
Turku 17
Columbus 16
Rome 16
Santa Clara 16
Boydton 15
Fairfield 15
Lawrence 15
Princeton 15
Warsaw 15
São Paulo 14
Houston 13
London 13
Tokyo 12
Nuremberg 11
Kazan' 10
Montreal 10
San Diego 10
Brooklyn 9
Council Bluffs 9
Helsinki 9
Johannesburg 9
Woodbridge 9
Brussels 8
Stockholm 8
Wuhan 8
Falls Church 7
Hanoi 7
Manchester 7
San Mateo 7
Turin 7
Wilmington 7
Chennai 6
Guangzhou 6
Redmond 6
San Francisco 6
Urbisaglia 6
Atlanta 5
Bangkok 5
Boston 5
Elk Grove Village 5
Jakarta 5
Porto Alegre 5
Salt Lake City 5
Toronto 5
Vienna 5
Amsterdam 4
Ankara 4
Ann Arbor 4
Biên Hòa 4
Botticino 4
Cambridge 4
Chaozhou 4
Charlotte 4
City of London 4
Denver 4
Kilburn 4
Perugia 4
Southwark 4
Ascoli Piceno 3
Brasília 3
Casablanca 3
Centro 3
Da Nang 3
Detroit 3
Dulles 3
Florence 3
Guarulhos 3
Heze 3
Milan 3
Orem 3
Philadelphia 3
Poços de Caldas 3
Rio de Janeiro 3
San Bernardo 3
Shijiazhuang 3
Taboão da Serra 3
Tashkent 3
Totale 2.371
Nome #
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 135
Oxidative stress and alterations of paraoxonases in atopic dermatitis 118
Long-term efficacy and safety of apremilast in the treatment of plaques psoriasis: A real-world, single-center experience 111
Review: A safety profile of dalbavancin for onand off-label utilization 108
The less-known face of dupilumab: its role in mesenchymal stem cells by interleukin-13 modulation 102
Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know 101
Combined treatment of palmar hyperhidrosis with botulinum toxin type A and oxybutynin chloride: Results of a clinical, multicenter, prospective study 101
Management of patients with pemphigus vulgaris during the COVID-19 pandemic: Experience of a second level dermatology center 99
Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma 94
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 91
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 88
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 88
Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review 88
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 86
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 83
Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review 81
Bullous Pemphygoid and Novel Therapeutic Approaches 80
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 80
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 80
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa 77
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis 73
Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study 72
Atypical Scleroderma-like Chronic GVHD in a Liver Transplant Patient, Clinical and MRI Correlations 72
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 69
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 69
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma 67
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 67
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management 66
The Role of Diet in Children with Psoriasis: Emerging Evidence and Current Issues 65
Biological treatments for pediatric psoriasis: state of the art and future perspectives 64
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 64
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy 64
Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma 63
Our Experience over 20 Years: Antimicrobial Peptides against Gram Positives, Gram Negatives, and Fungi 60
CT patterns of interstitial lung disease in patients with plaque psoriasis: a retrospective case series study 58
MRSA and Skin Infections in Psoriatic Patients: Therapeutic Options and New Perspectives 57
Bimekizumab in hidradenitis suppurativa: a valid and rapid emerging treatment 57
Efficacy of Pembrolizumab in Advanced Melanoma: A Narrative Review 57
New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa 56
Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues 56
The sources of antimicrobial peptides against Gram-positives and Gramnegatives: our research experience 55
Successful use of dalbavancin in the management of severe hidradenitis suppurativa 54
Role of antioxidants supplementation in the treatment of atopic dermatitis: a critical narrative review 53
Role of Daptomycin in Cutaneous Wound Healing: A Narrative Review 48
Role of daptomycin in cutaneous wound healing: a narrative review 46
New insight into old and new antimicrobial molecules targeting quorum sensing for MRSA wound infection 43
Mortality and prognostic factors in patients with bullous pemphigoid: a retrospective multicenter Italian study 40
Topical and Systemic Retinoids in the Management of Hidradenitis Suppurativa: A Comprehensive Literature Review 38
New perspectives on old and new therapies of staphylococcal skin infections: the role of biofilm targeting in wound healing. 27
Totale 3.571
Categoria #
all - tutte 20.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.449


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 0 0 0 0 25 3
2021/2022153 10 9 1 4 16 7 2 3 13 3 47 38
2022/2023563 28 44 25 54 32 194 0 23 91 2 43 27
2023/2024503 53 8 64 64 65 120 15 41 4 23 5 41
2024/20251.056 142 67 37 8 48 41 117 36 203 76 162 119
2025/20261.268 245 170 232 304 292 25 0 0 0 0 0 0
Totale 3.571